About
Venture partner focused on company creation, bringing both investment and drug discovery expertise. Previously a general partner at Mubadala Capital building its U.S. healthcare platform, co-founder and CEO of EpiBiologics, and a 16+ year Genentech R&D leader in oncology and immunology. Holds a Ph.D. in Chemistry from McGill with postdoctoral training at Harvard.
Colleagues at Versant Ventures
Alex Mayweg
Managing Director at Versant Ventures
Alicia Levey
Venture Partner at Versant Ventures
Andrew Jefferson
Operating Partner at Versant Ventures
Ariel Kantor
Principal at Versant Ventures
Barbara Lubash
Managing Director at Versant Ventures
Beckie Robertson
Managing Director at Versant Ventures
Bill Link
Investor at Versant Ventures
Brad Bolzon
Chairman, Managing Director at Versant Ventures